Products for Research Use Only

TPI-1917-49

CAT: 0804-HY-118972Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-118972Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
TPI-1917-49 is an agent that can cross the blood-brain barrier and reduce amyloid β (Aβ) . TPI-1917-49 reduces the production of Aβ peptide segments by promoting the non-amyloidogenic pathway of amyloid precursor protein (APP) (increasing the generation of sAPPα mediated by α-secretase) . TPI-1917-49 reduces amyloid plaques in mouse models. TPI-1917-49 can be used in Alzheimer's disease research[1].
CAS Number
1250849-11-6
UNSPSC
12352005
Target
Amyloid-β
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Smiles
O=C(C1=CC=C(C(NC2=NC(C3=CC=CC(O)=C3)=CS2)=C1)N4CCN(CC4)C5=NC(C6=CC=CC(O)=C6)=CS5)N
Molecular Formula
C29H26N6O3S2
Molecular Weight
570.69
References & Citations
[1]Wang H, et al. Substituted dithiazole piperazine benzamides as novel amyloid beta peptide reducing agents. Bioorg Med Chem Lett. 2014 Sep 15;24 (18) :4384-4388.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported